Helen C. Adams - 15 Dec 2021 Form 3 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Director
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Helen C. Adams
Issuer symbol
IMMX
Transactions as of
15 Dec 2021
Net transactions value
$0
Form type
3
Filing time
15 Dec 2021, 20:03:07 UTC
Previous filing
16 Nov 2021
Next filing
20 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IMMX Options (right to purchase) 15 Dec 2021 Common stock 37,500 $1.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 18, 2021, the Registrant issued the Reporting Person options to purchase up to 37,500 shares of the Registrant's common stock (the "Options"). The Options vest in 48 monthly installments with the first installment vesting on June 18, 2021, subject to the Reporting Person's continued service with the Registrant.

Remarks:

Exhibit List: Exhibit 24.1 - Powers of Attorney